Pharmaceutical companies will need to engage meaningfully with a broader stakeholder set in India, beyond just physicians, amid the growing influence of these groups in prescription decisions in the country. This at least is the major finding of a survey by management consultancy Bain & Company in collaboration with the Confederation of Indian Industry (CII).
While almost 80% of physicians covered in the Indian survey indicated that they find it challenging to keep pace with...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
